Comparative Pharmacology

Head-to-head clinical analysis: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE versus INDERIDE 80 25.

Peer-Reviewed Evidence

Differential Analysis

FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE vs INDERIDE-80/25

Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.

FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE

Thiazide Diuretic

Category A/B

INDERIDE-80/25

Beta Blocker and Thiazide Diuretic

Category C

Head-to-Head

Clinical Matrix

Mechanism of Action

Fosinopril is an ACE inhibitor that inhibits the conversion of angiotensin I to angiotensin II, reducing vasoconstriction and aldosterone secretion. Hydrochlorothiazide is a thiazide diuretic that inhibits the sodium-chloride symporter in the distal convoluted tubule, increasing excretion of sodium and water.

INDERIDE-80/25 is a combination of propranolol (a non-selective beta-adrenergic receptor antagonist) and hydrochlorothiazide (a thiazide diuretic). Propranolol blocks beta-1 and beta-2 adrenergic receptors, reducing heart rate, myocardial contractility, and renin release, thereby lowering blood pressure. Hydrochlorothiazide inhibits the sodium-chloride symporter in the distal convoluted tubule of the kidney, increasing excretion of sodium, chloride, and water, reducing plasma volume.

Clinical Dosing

1 tablet (fosinopril 10 mg/hydrochlorothiazide 12.5 mg or fosinopril 20 mg/hydrochlorothiazide 12.5 mg) orally once daily. Maximum dose: fosinopril 80 mg/hydrochlorothiazide 50 mg per day.

One tablet (80 mg propranolol/25 mg hydrochlorothiazide) orally twice daily.

Direct Interaction

None Documented